Key highlights

  • ALS reported record low safety rates in FY26, with a TRIFR of 0.79 and an LTIFR of 0.29, according to its 28 July 2026 AGM address.
  • Minerals delivered 20.2% organic growth, Food 7.2% and Oil & Lubricants 12.2%, while Pharma revenue declined 1.6% organically.
  • The company signed an agreement to lift its holding in its Saudi joint venture operation to 60%, pending regulatory approvals.

Als Ltd (ASX:ALQ) closed 21 October 2026 at $20.15, higher by 0.40%. Across the market, the S&P/ASX 200 Industrials [XNJ] index settled at 8,113.90, higher by 0.99% or 79.50 points, and the S&P/ASX 200 [XJO] at 8,831.30, higher by 0.16% or 14.40 points, at 4:25 pm GMT+11. ALS is a global testing, inspection and certification company with operations in commodities, life sciences and other testing markets.

What ALS does

ALS Limited provides laboratory testing and related services to customers in the commodities and life sciences sectors. Its Commodities business covers Minerals, Coal, Metallurgy, Industrial Materials and Oil & Lubricants, and its Life Sciences business covers Environmental, Food, Pharma and related testing. The company states that its Environmental business is its largest at about 35% of Group revenue.

FY26 performance in the AGM address

In an ASX release dated 28 July 2026, ALS published the address of its CEO and Managing Director to the 2026 Annual General Meeting, delivered remotely from Europe. The address describes FY26 as delivering record financial performance and returns, and sets out results by division.

In Commodities, Minerals delivered 20.2% organic growth in a record year, with margin expanding to 33%. Coal grew 7.6% organically and Oil & Lubricants 12.2%, though both saw margin contraction. In Life Sciences, Food delivered 7.2% organic growth for the third consecutive year, led by Europe. Pharma recorded a 1.6% organic revenue decline, while Nuvisan EBIT grew 123% with margin about 450 basis points higher after the successful completion of its transition.

Safety, strategy and technology

ALS reported a record low total recordable injury frequency rate of 0.79 and lost time injury frequency rate of 0.29. The address sets out the Roadmap to Win, a strategic blueprint that prioritises high-volume analytical testing and associated services in markets where ALS can build a competitive advantage. It also describes a Lab of the Future digital program: the unified LIMS supports 80% of Group revenue, and the company describes AI deployments across its operations.

Saudi joint venture and trading update

The CEO said ALS signed an agreement to acquire an additional 18% interest in its Saudi joint venture operation, taking its total holding to 60%, pending regulatory approvals. The address also contains an update on first-quarter trading and the year ahead, and notes the departure of a long-serving director from the Board.

Sector context

Industrial companies span transport, infrastructure, engineering, services and manufacturing, and they are tracked through the S&P/ASX 200 Industrials index, which closed at 8,113.90, up 0.99%, on 21 October 2026 alongside a 0.16% rise in the S&P/ASX 200 to 8,831.30. Testing services demand is linked to mining and exploration activity, environmental regulation, food safety and pharmaceutical development.

Risks and uncertainties

Pharma revenue declined organically, and Coal and Oil & Lubricants experienced margin contraction despite revenue growth. The Saudi interest increase depends on regulatory approvals. Commodity cycles, laboratory capacity, labour costs, currency and regulatory changes can affect results, and the address is a speech rather than a full financial report.

Catalysts to watch

Items to watch include regulatory approval of the Saudi JV stake, progress on the Roadmap to Win and Lab of the Future, Pharma and Nuvisan results, and ALS’s first-half FY27 result.

Closing perspective

ALS’s 28 July 2026 AGM address summarised record safety and financial results, divisional growth and a larger Saudi stake. Subsequent results will provide formal figures for the period ahead.